Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants.
Larghero J, Rocha V, Porcher R, Filion A, Ternaux B, Lacassagne MN, Robin M, Peffault de Latour R, Devergie A, Biscay N, Ribaud P, Benbunan M, Gluckman E, Marolleau JP, Socié G. Larghero J, et al. Among authors: devergie a. Br J Haematol. 2007 Jul;138(1):101-9. doi: 10.1111/j.1365-2141.2007.06623.x. Br J Haematol. 2007. PMID: 17555453 Free article.
Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia.
Guardiola P, Kurre P, Vlad A, Cayuela JM, Espérou H, Devergie A, Ribaud P, Socié G, Richard P, Traineau R, Storb R, Gluckman E. Guardiola P, et al. Among authors: devergie a. Br J Haematol. 2003 Sep;122(5):806-9. doi: 10.1046/j.1365-2141.2003.04503.x. Br J Haematol. 2003. PMID: 12930393 Free article.
Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.
Guardiola P, Socié G, Li X, Ribaud P, Devergie A, Espérou H, Richard P, Traineau R, Janin A, Gluckman E. Guardiola P, et al. Among authors: devergie a. Blood. 2004 Jan 1;103(1):73-7. doi: 10.1182/blood-2003-06-2146. Epub 2003 Aug 28. Blood. 2004. PMID: 12946993 Free article.
Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M, Porcher R, De Castro Araujo R, de Latour RP, Devergie A, Rocha V, Larghero J, Adès L, Ribaud P, Mary JY, Socié G. Robin M, et al. Among authors: devergie a. Biol Blood Marrow Transplant. 2007 Nov;13(11):1304-12. doi: 10.1016/j.bbmt.2007.07.007. Epub 2007 Sep 7. Biol Blood Marrow Transplant. 2007. PMID: 17950917 Free article.
Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants.
Michonneau D, Peffault de Latour R, Porcher R, Robin M, Benbunan M, Rocha V, Ribaud P, Ferry C, Devergie A, Vanneaux V, Gluckman E, Marolleau JP, Socié G, Larghero J. Michonneau D, et al. Among authors: devergie a. Br J Haematol. 2009 Apr;145(1):107-14. doi: 10.1111/j.1365-2141.2008.07574.x. Epub 2009 Jan 12. Br J Haematol. 2009. PMID: 19183190 Free article.
213 results